Stock Taper
SCREENER COMPARE ANY 2 STOCKS
COCP
COCRYSTAL PHARMA, INC.
NASDAQ
$1.10
▼ DOWN 3.51% (-0.04)

KEY STATISTICS

Market Cap$15.17 M
52w High$2.67
52w Low$0.76
Dividend Yield—
Frequency—
P/E-1.45
Volume28.74K
Shares Out.13.79M

COMPANY

LEADERSHIP

James E. Sapirstein
CHIEF EXECUTIVE
James E. Sapirstein

COMPENSATION 2026

Salary$265,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$265,000

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 22, 2012
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
10

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.$105.00K
NOV
13
FRI

SPLIT RECORD

DATETYPERATIO
2022-10-11Reverse1:12
2018-01-24Reverse1:30
2011-05-19Forward10:1
2011-03-15Forward10:1

PRICE

$1.10 ▼ DOWN 3.51% (−$0.04)
OVERLAYS
$1.13$1.14$1.159:56 AM10:56 AM11:57 AM12:57 PM1:58 PM2:59 PM3:59 PM1.10

About Cocrystal Pharma, Inc.

https://www.cocrystalpharma.com ↗

Cocrystal Pharma, Inc. is a biotech firm developing antiviral drugs for diseases like HCV, influenza, coronavirus, and norovirus, with several candidates in clinical and preclinical stages and collaborations with Merck, Kansas State, HitGen, and I...

INDUSTRY

Biotechnology

A PRODUCT COCRYSTAL PHARMA, INC. IS KNOWN FOR

CDI-988
CDI-988

The company’s leading antiviral drug candidate, in Phase 1b testing, aims to prevent and treat norovirus infections, with no current approved treatments or vaccines available.

COMPETITORS

COMPETITOR
ALGS COMPARE
AVIR COMPARE
ENTA COMPARE
VXRT COMPARE

Revenue by Products

IconPRODUCTQ2-2020Q3-2020Q1-2026Q2-2026
Collaboration Revenue$554K $489K ▼— —
Segments— — $225K $330K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
10
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 187.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
5.84%
HOLDERS
33
TOP 12 OF 33 · RANKED BY POSITION SIZE
Vanguard Group Inc
268.1K sh · $335.1K
Renaissance Technologies LLC
127.9K sh · $159.91K
Geode Capital Management, LLC
90.2K sh · $91.15K
Blackrock Inc.
73.7K sh · $171.83K
Blackrock, Inc.
73.7K sh · $74.48K
Xtx Topco Ltd
36.0K sh · $36.39K
Drw Securities, LLC
33.6K sh · $32.89K
Neuberger Berman Group LLC
31.9K sh · $32.2K
Jane Street Group, LLC
21.0K sh · $26.3K
State Street Corp
20.5K sh · $20.75K
Two Sigma Securities, LLC
15.3K sh · $15.41K
Virtu Financial LLC
13.1K sh · $13K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR:
Brosgart Carol L
— · —
2026-08-12
★
DIRECTOR, 10 PERCENT OWNER:
FROST PHILLIP MD ET AL
Purchase · 10.0K shares
2026-08-05
★
DIRECTOR, 10 PERCENT OWNER:
FROST PHILLIP MD ET AL
Purchase · 75.0K shares
2026-08-03
★
OFFICER
SAPIRSTEIN JAMES
— · —
2026-06-03

SECTORS PEERS

PEERPRICE
DWTX$2.65COMPARE
CING$5.33COMPARE
MRKR$1.37COMPARE
TRAW$0.59COMPARE
IMRN$1.15COMPARE
BOLT$3.81COMPARE
IMNN$1.60COMPARE
BRTX$0.20COMPARE